Skip to main content
Signal8

Payne Joseph E

SEC insider (Form 3/4/5 filer). CIK 0001727315. President and CEO at Arcturus Therapeutics Holdings Inc. (ARCT). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in SAN DIEGO, CA.

Companies Payne Joseph E has filed insider reports for

  • Arcturus Therapeutics Holdings Inc. (ARCT): Director, Officer, President and CEO
Payne Joseph E profile photo

Payne Joseph E

CIK: 0001727315

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcturus Therapeutics Holdings Inc. logo
ARCT

Arcturus Therapeutics Holdings Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 17, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    175K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Dec 16, 2024
    Award

    Employee Stock Option (right to buy)

    Direct
    196K shares-

1-2 of 2